Search

everythinglearnresearchcommunity

for

Search:↓

Folliculotropic mycosis fungoides has a worse prognosis than other types, with survival rates varying significantly based on subtype and organ involvement.

Most skin tumors in the study were benign, with squamous cell carcinoma being the most common malignant type.

Platelet-rich plasma is a promising and cost-effective treatment for hair and skin issues in older adults in India.

The COVID-19 pandemic changed the types of skin conditions seen at a clinic, with fewer patients and varying numbers of specific conditions.

PRP is a versatile and affordable treatment for improving appearance in the elderly, with patient needs and expectations being important.

The vitreous membrane in hair follicles changes shape during the hair cycle and may affect hair growth and nutrient exchange.

People with telogen effluvium and scalp discomfort might have low vitamin B12 and could benefit from B12 supplements.

Discoid Lupus Erythematosus often causes scarring hair loss, is influenced by genetics and environment, and requires early treatment to prevent worsening.

Mindfulness reduces anxiety and depression in skin disease patients; dermatologists and psychiatrists often lack confidence in treating psychodermatological conditions.

Higher levels of nidogen1 and type IV collagen are found in basal cell carcinoma compared to normal skin.

CREB, a protein that can promote cancer traits, is controlled by β-catenin in skin cancer cells.

The document concludes that ERBB2 mutations are common in extramammary Paget disease and may respond to systemic treatments like cancer immunotherapy.

Samcyprone ointment is effective for treating common warts if a sensitization reaction occurs first.

FOL-005, a hair growth promoter, acts locally on mouse skin where injected and could be a promising hair loss treatment.

Cancer treatments targeting specific cells often cause skin, hair, and nail problems, affecting patients' lives and requiring careful management.

The document concludes that scalp conditions have various causes and can present in many different ways.

The new treatment was safe and may effectively treat male pattern hair loss.

The new baby shampoo and wash with stearic acid is safe and potentially effective for nourishing babies' skin.

A thorough skin history and examination are essential for diagnosing and treating skin conditions effectively.

Retinoids are effective for skin conditions like severe acne and psoriasis but must be used with caution due to potential side effects and risks during pregnancy.

Young men taking finasteride for hair loss have a higher risk of sexual dysfunction.

The document covers various dermatological treatments and conditions.

Eczema patients have a lower skin lipid to protein ratio, older and longer-staying hospital patients are more likely to get pressure ulcers, hair loss in AGA is linked to muscle degeneration, vitamin D deficiency is common in alopecia areata and linked to its severity, standard liver tests don't effectively detect fibrosis in psoriasis patients on methotrexate, and bullous pemphigoid patients have a higher death risk but combination therapy may reduce it.

Chemotherapy can cause skin issues and hair loss, and this guide explains how to manage them.

The document reviews key historical figures and discoveries in dermatology.

Hair loss treatments show limited improvement, sunscreen thickness affects vitamin D production, and the effectiveness of IVIg for toxic epidermal necrolysis is uncertain.

Temporal triangular alopecia is a lifelong condition with hairless patches on the side of the head that may be present from birth.

The document shows the state of pharmaceutical patents as of 1999, focusing on treatments for various diseases.

The document concludes that low-dose acne treatment is most suitable for moderate acne, with high patient satisfaction and low relapse rates.

The document concludes that new treatments for skin conditions are complex but effective, including spironolactone for female hair loss and propranolol for infantile hemangiomas.